Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency
NCT02616484Phase 3Active, not recruiting
- Sponsor
- Saol Therapeutics
- Start
- Jul 2020
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dichloroacetate in Pyruvate dehydrogenase complex deficiency (PDCD), sponsored by Saol Therapeutics. Started Jul 2020; status: active, not recruiting.
02
Drugs
dichloroacetate
03
Conditions
Pyruvate dehydrogenase complex deficiency (PDCD)
Beyond the preview
Go deeper on NCT02616484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616484.